If you have been diagnosed with non-melanoma skin cancer, learn more about a gentler way to treat skin cancer.

Our Story

Our Story

How It All Began

In 2016, our cofounder submitted a graduate thesis on the use of superficial radiation treatment as an alternative to Mohs surgery. Today, Image-Guided SRT is being used at more than 315 dermatology practices in the United States with extraordinary results.



Marie Curie discovers radiation.

Wilhelm Röntgen discovers a new ray and calls it the X-ray.


In Chicago, IL, Dr. Emile Grubbe experiments with the use of x-rays to treat cancer.

Henri Coutard develops the first fractionated course of radiation treatment for cancer.


Use of superficial radiotherapy to treat skin cancer begins to reach its peak. The American Academy of Dermatology reports that more than 50% of dermatology practices use superficial radiotherapy equipment (1974).

Dermatology residency programs begin offering Mohs surgical training. Government regulations make it more difficult to offer radiotherapy in a practice setting and shifts in reimbursement rates make it difficult for practices to justify the expense involved in offering radiotherapy.


Few dermatology practices in the US offer superficial radiotherapy. Mohs becomes the go-to treatment option for non-melanoma skin cancer treatment.

Sensus Healthcare manufactures the first Image-Guided SRT device.

January 2015
June 2015

A dermatology practice in Texas becomes the first to commit to the transition from SRT to IG-SRT.

First patient treated for non-melanoma skin cancer using IG-SRT. The RTT providing treatment will later become our Chief Operating Officer.

December 2015
February 2016

S. Scott submits his master’s thesis “The Integration of Superficial Radiotherapy for Skin Cancer in a Dermatologic Practice.”

SkinCure Oncology is born.

October 2016
January 2017

10 dermatology practices offer IG-SRT

1,000th patient treated with IG-SRT

September 2017
June 2018

50 practices offer IG-SRT

5,000th patient treated with IG-SRT

November 2018
July 2019

10,000th patient treated with IG-SRT

100 practices offer IG-SRT

August 2019
January 2020

15,000th patient treated with IG-SRT

20,000th patient treated with IG-SRT

August 2020
October 2020

130 practices offer IG-SRT

25,000th patient treated with IG-SRT

January 2021
June 2022

200 practices offer IG-SRT

50,000th patient treatment with IG-SRT

December 2022
June 2023

250 practices offer IG-SRT